Skip to content
Company Analysis

AngioDynamics, Inc. ANGO

A comprehensive view of key metrics, scores, and financial health for AngioDynamics, Inc.

Overview of AngioDynamics, Inc.

ANGO NMS
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Small Cap
AngioDynamics, Inc. (ANGO), is a Small Cap company, in the Medical Instruments & Supplies industry, last closed at $12.10, about 23.6% overvalued vs fair value, +13.5% 1Y return, ranked 666/1122 in sector.
Metrics Rev Growth -3.8% ROE -17.5% Gross Margin 53.9%
USD 12.10
0.17%
(Delayed)
• Vol 90d: 45.5%
52-Week Range
Market Cap
$507.40M
Enterprise Value
$477.55M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Fair
Growth
Fair
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Fair
Completeness: 82%
Confidence: 87%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.angiodynamics.com
HQ Latham, NY
Employees 675
Fiscal year May 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$8
$9
$11
Current: $12.10 -24% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$292.5M
-3.8%%
Gross Profit
$157.7M
1.9%%
Operating Income (GAAP)
$-24.1M
28.9%%
EBITDA
$1.7M
128.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
53.9%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$1.7M

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
1/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating AngioDynamics, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
52
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
62
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing ANGO's balance between Growth (30.5%), Profitability (38.1%), and Safety (31.5%). Growth 30% Safety 31% Profitability 38%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

40th percentile vs peers
41
Key Signals
EPS Growth YoY 81.9% 85p Rev Growth YoY -3.8% 23p Revenue CAGR 3Y -2.6% 24p Asset Growth YoY -11.8% 28p
Strengths
  • EPS Growth YoY in top 20% of peers (81.9%, 85th percentile)
Risks
  • Growth below peer median (percentile: 40)

Profitability

50th percentile vs peers
51
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

41th percentile vs peers
42
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for AngioDynamics, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$9.24
- - -
-23.6% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000